Columbia Neurosurgery’s Cerebrovascular Division Leads at the 2024 American Heart Association International Stroke Conference (ICS)
At the Cutting Edge of Stroke Care
Members of our Cerebrovascular Division, Dr. Sean Lavine (Division Chief), Dr. Eleonora Spinazzi (Chief Resident) and Gabriella Tosto-D’Antonio (DNP) attended the American Heart Association’s International Stroke Conference last week in Phoenix, AZ. The ICS is “the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease and brain health.” Our team took part in combining their expertise, experience, and background in exceptional education and science through presentations on the latest research from global thought leaders.
Chief Resident Dr. Eleonora Spinazzi (PGY-7) presented her original research on behalf of the entire Cerebrovascular Division: Microanatomy of Intracranial Human Thrombi by Single Nuclei Transcriptomics.
Dr. Sean Lavine stated, “Dr. Spinazzi’s novel investigation was incredibly well-received by the scientific community. This pivotal research investigated the cellular landscape of clots removed during acute endovascular stroke treatment and will guide post-stroke treatment for many patients in the future.”
The Cerebrovascular Team was also excited to be present for the presentation of a landmark Study, ENRICH, which, for the first time, documented clinical benefit for the surgical removal of intracranial bleeds in the lobes of the brain. Along with all physicians involved in the care of cerebral blood vessel disease, the Columbia team looks forward to the timely publication of this data.
In another compelling conference, Columbia Neurosurgery was honored to join the world’s leaders in stroke care and take the opportunity to share best practices and insights into how the team’s interdisciplinary care model has evolved this year, most notably with the treatment of venous pathology in the brain and spine. The team looks forward to next year’s program and continuing the conversation across numerous topics emphasizing basic, clinical, and translational science to understand stroke pathophysiology further, develop effective therapies and explore brain health and stroke recovery.
